0001140361-23-048587.txt : 20231017
0001140361-23-048587.hdr.sgml : 20231017
20231017214019
ACCESSION NUMBER: 0001140361-23-048587
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20231017
DATE AS OF CHANGE: 20231017
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Roivant Sciences Ltd.
CENTRAL INDEX KEY: 0001635088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981173944
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40782
FILM NUMBER: 231330828
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON HM11
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-295-5950
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMTAZEE JAMES C
CENTRAL INDEX KEY: 0001209181
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 2884 SAND HILL ROAD, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
144
1
primary_doc.xml
144
0001209181
XXXXXXXX
LIVE
0001635088
Roivant Sciences Ltd.
001-40782
7th Floor
50 Broadway
London
X0
SW1H 0DB
207 400 3347
MOMTAZEE JAMES C
Director
Common shares, $0.0000000341740141 par value per share (???Common Shares???)
E*TRADE FINANCIAL CORPORATION
3 EDISON DRIVE
ALPHARETTA
GA
30005
687
7000.53
771742197
10/17/2023
NASDAQ
Common Shares
10/16/2023
Award of Common Shares granted under the Roivant Sciences Ltd. 2021 Equity Incentive Plan
Roivant Sciences Ltd.
N
687
10/16/2023
N/A
N
James C. Momtazee
c/o Roivant Sciences Ltd.
7th Floor, 50 Broadway
London
X0
SW1H 0DB
Common Shares
09/18/2023
6752
75419.84
The securities included in Table I represent shares sold to cover the reporting person's tax obligations when an award of Common Shares belonging to the reporting person are settled. The securities included in Table II represent shares sold to cover the reporting person's tax obligations when an award of Common Shares belonging to the reporting person was settled. The securities reported in Tables I and II do not represent discretionary trades by the reporting person, and will be sold, or were sold, as applicable, for the limited purpose of satisfying tax withholding obligations.
10/17/2023
02/15/2022
/s/ Jo Chen, as Attorney-in-Fact for James C Momtazee